US Pharma MarketingGenerate:Biomedicines discloses early respiratory drug data after congress poster leak
Generate:Biomedicines reveals early Phase 1 GB-0895 data after an ERS poster leak, showing sustained biomarker suppression in asthma, COPD. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo…
Generate:Biomedicines shared Phase 1 data for its respiratory disease drug as part of the European Respiratory Society's (ERS) annual meeting after posters were prematurely released two weeks ahead of schedule.
Generate had been planning to ...
Source: Endpoints News